Cell Expansion Global Market-Forecast to 2022

Publishing Date : October, 2016
Report Code : HCBT0111
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Cell expansion technology is emerging as a promising therapeutic solution for many diseases and is used for engineering, replacing, or regenerating human tissues, cells, and organs to restore normal function. Products of cell expansion market are segmented into instruments and consumables. The instruments are segmented into cell expansion supporting instruments, bioreactors and automatic cell expansion systems. Cell expansion supporting equipment include flow cytometer, centrifuge, cell counters and others. Bioreactors are segmented into stirred type bioreactors, micro carrier-based anchorage-dependent stirred type bioreactors, suspension-based anchorage independent stirred type bioreactors, hollow fibre/perfusion bioreactors, bubble column and airlift bioreactor, single/disposable use bioreactor and others. Consumables are segmented into reagents, media, sera and disposables. Disposables are further sub-segmented into culture vessels, bioreactor accessories and others.

By cell types, the cell expansion markets are divided into animal cells, human cells, bacterial cells and others. The human cell includes adult stem cells, induced pluripotent stem cells and embryonic stem cells. Adult stem cells are segmented into mesenchymal stem cells, hematopoietic stem cells and neural stem cells. Others include yeast cells and insect cells.

By application, the cell expansion markets are divided into regenerative medicine and stem cell research, cancer studies and others.  The end users of the cell expansion market are segmented into academics and research institutes, biotechnology and biopharmaceutical companies, hospital, biobanks and others.

Among the cell expansion products, the consumables dominated the market by occupying a largest share and instruments market is estimated to be the fastest growing segment from 2015 to 2022. In cell types, human cell types are the largest segment as well as the fastest growing segment. In applications, the regenerative medicine and stem cell research is the largest segment and is the fastest growing segment with a highest CAGR of 18.1% from 2015-2022. By end- users, hospitals and bio banks are the largest segment with a share of 37.0% and also, the fastest segment from 2015 to 2022.

Geographically, North America is the largest market followed by Europe and Asia. The APAC region is the fastest growing region with a CAGR of 20.8% from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the cell expansion market. Growth in the Asian market is attributed to rising prevalence of chronic diseases and increased government initiatives for stem cell research.

The cell expansion market is expected to grow at a double digit CAGR to reach $23,997 million by 2022. Rising prevalence of chronic diseases, increasing government funding for research, increased investments in cell based products, growing number of GMP-certified production facilities and 3D cell expansion technology are some of the drivers in the cell expansion global market. High cost of cell-based research, use of unregulated products, quality issues for end users, ethical concerns regarding research on cell biology and stringent regulation are some of the factors hampering the market.

The cell expansion global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the cell expansion market are Becton Dickinson and Company (U.S.), Corning, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), GE Healthcare (U.K), Lonza Group Ltd. (Switzerland), Merck KGAA (Germany.), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Terumo Corporation (Japan) and ThermoFisher Scientific Inc. (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET CRACKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     RISING PREVALENCE OF CHRONIC DISEASES
        • 3.3.1.2     INCREASING GOVERNMENT FUNDING FOR RESEARCH
        • 3.3.1.3     INCREASED INVESTMENTS IN CELL BASED RESEARCH
        • 3.3.1.4     GROWING NUMBER OF GMP-CERTIFIED PRODUCTION FACILITIES.
        • 3.3.1.5     3D CELL EXPANSION TECHNOLOGY
        • 3.3.1.6     COUNTRIES IN ASIA-PACIFIC REGION TO PRESENT HIGH-GROWTH OPPORTUNITIES
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     HIGH COST OF CELL-BASED PRODUCTS
        • 3.3.2.2     USE OF UNREGULATED PRODUCTS
        • 3.3.2.3     QUALITY ISSUES FOR END USERS
        • 3.3.2.4     ETHICAL CONCERNS REGARDING RESEARCH ON CELL BIOLOGY
        • 3.3.2.5     STRINGENT REGULATION
    • 3.4     PORTER’S FIVE FORCE ANALYSIS
      • 3.4.1     THREAT OF NEW ENTRANTS
      • 3.4.2     THREAT OF SUBSTITUTES
      • 3.4.3     BARGAINING POWER OF SUPPLIERS
      • 3.4.4     BARGAINING POWER OF BUYERS
      • 3.4.5     COMPETITIVE RIVALRY
    • 3.5     REGULATORY GUIDELINES
      • 3.5.1     U.S.
      • 3.5.2     EUROPE
      • 3.5.3     INDIA
      • 3.5.4     CHINA
      • 3.5.5     JAPAN
    • 3.6     UPCOMING TECHNOLOGIES
    • 3.7     SUPPLY CHAIN ANALYSIS
    • 3.8     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.8.1     CELL EXPANSION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015
      • 3.8.2     SINGLE-USE BIOREACTOR MARKET REVENUE, BY MAJOR PLAYERS, 2015
    • 3.9     PATENT TRENDS
  • 4     CELL EXPANSION GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     INSTRUMENTS
      • 4.2.1     CELL EXPANSION SUPPORTING EQUIPMENTS
        • 4.2.1.1     FLOW CYTOMETERS
        • 4.2.1.2     CENTRIFUGE
        • 4.2.1.3     CELL COUNTERS
        • 4.2.1.4     OTHER CELL EXPANSION SUPPORTING EQUIPMENTS
      • 4.2.2     BIOREACTORS
        • 4.2.2.1     STIRRED TYPE BIOREACTORS
        • 4.2.2.2     MICROCARRIER-BASED ANCHORAGE-DEPENDENT STIRRED TYPE BIOREACTORS
        • 4.2.2.3     SUSPENSION-BASED ANCHORAGE INDEPENDENT STIRRED TYPE BIOREACTORS
        • 4.2.2.4     HOLLOW FIBER/PERFUSION BIOREACTORS
        • 4.2.2.5     BUBBLE COLUMN AND AIRLIFT BIOREACTORS
        • 4.2.2.6     SINGLE USE/DISPOSABLE BIOREACTORS
        • 4.2.2.7     OTHER BIOREACTORS
      • 4.2.3     AUTOMATED CELL EXPANSION SYSTEMS
    • 4.3     CONSUMABLES
      • 4.3.1     REAGENTS, MEDIA AND SERA
      • 4.3.2     DISPOSABLES
        • 4.3.2.1     CULTURE VESSELS
        • 4.3.2.2     BIOREACTOR ACCESSORIES
        • 4.3.2.3     OTHERS
  • 5     CELL EXPANSION GLOBAL MARKET, BY TYPES
    • 5.1     INTRODUCTION
    • 5.2     ANIMAL CELL
    • 5.3     HUMAN CELL
      • 5.3.1     ADULT STEM CELL
        • 5.3.1.1     NEURAL STEM CELLS (NSCS)
        • 5.3.1.2     HEMATOPOIETIC STEM CELLS (HSCS)
        • 5.3.1.3     MESENCHYMAL STEM CELLS (MSC)
      • 5.3.2     INDUCED PLURIPOTENT STEM CELL (IPSC)
      • 5.3.3     EMBRYONIC STEM CELL
    • 5.4     BACTERIAL CELLS
    • 5.5     OTHERS
  • 6     CELL EXPANSION GLOBAL MARKET, BY APPLICATIONS
    • 6.1     INTRODUCTION
    • 6.2     REGENERATIVE MEDICINE AND STEM CELL RESEARCH
    • 6.3     CANCER STUDIES
    • 6.4     OTHERS
  • 7     CELL EXPANSION GLOBAL MARKET, BY END USERS
    • 7.1     INTRODUCTION
    • 7.2     ACADEMIC AND RESEARCH INSTITUTES
    • 7.3     BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANY
    • 7.4     HOSPITALS AND BIO BANKS
    • 7.5     OTHERS
  • 8     REGIONAL MARKET ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
    • 8.3     EUROPE
    • 8.4     ASIA PACIFIC
    • 8.5     REST OF THE WORLD
  • 9     COMPANY DEVELOPMENTS
    • 9.1     INTRODUCTION
      • 9.1.1     NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF CELL EXPANSION MARKET PLAYERS
    • 9.2     NEW PRODUCT LAUNCH
    • 9.3     AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES
    • 9.4     OTHER DEVELOPMENTS
    • 9.5     MERGER AND ACQISITION
  • 10     COMPANY PROFILE
    • 10.1     BECTON, DICKINSON AND COMPANY (CAREFUSION CORPORATION)
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     CORNING, INC.
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     DANAHER CORPORATION
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     EPPENDORF AG
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY
      • 10.4.6     SWOT ANALYSIS
    • 10.5     GE HEALTHCARE
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     LONZA GROUP LTD.
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     MERCK KGAA
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     MILTENYI BIOTEC GMBH
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     STEMCELL TECHNOLOGIES
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.1     TERUMO CORPORATION
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS
    • 10.11     THERMOFISHER SCIENTIFIC, INC.
      • 10.11.1     OVERVIEW
      • 10.11.2     FINANCIALS
      • 10.11.3     PRODUCT PORTFOLIO
      • 10.11.4     KEY DEVELOPMENTS
      • 10.11.5     BUSINESS STRATEGY
      • 10.11.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     CELL EXPANSION GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 2     CELL EXPANSION GLOBAL MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
      • TABLE 3     CELL EXPANSION GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 4     CELL EXPANSION GLOBAL MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
      • TABLE 5     CELL EXPANSION GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 6     CELL EXPANSION INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 7     CELL EXPANSION INSTRUMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 8     CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 9     CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 10     FLOW CYTOMETER GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 11     CENTRIFUGE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 12     CELL COUNTER GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 13     OTHER CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 14     BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 15     BIOREACTORS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 16     STIRRED TYPE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
      • TABLE 17     MICROCARRIER-BASED ANCHORAGE-DEPENDENT STIRRED TYPE BIOREACTORS GLOBALMARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 18     SUSPENSION-BASED ANCHORAGE INDEPENDENT STIRRED TYPE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 19     HOLLOW FIBER PERFUSION BIOREACTORS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
      • TABLE 20     BUBBLE COLUMN AND AIRLIFT BIOREACTOR GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
      • TABLE 21     SINGLE USE/DISPOSABLE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 22     OTHER BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 23     AUTOMATED CELL EXPANSION SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 24     CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 25     CONSUMABLES GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 26     REAGENTS, MEDIA AND SERA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 27     DISPOSABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 28     DISPOSABLES GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 29     CULTURE VESSELS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 30     BIOREACTOR ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 31     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 32     CELL EXPANSION GLOBAL MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
      • TABLE 33     ANIMAL CELL GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 34     HUMAN CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 35     HUMAN CELL GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 36     ADULT STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 37     ADULT STEM CELL GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 38     NEURAL STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 39     HEMATOPOITIC STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 40     MESENCHYMAL STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 41     INDUCED PLURIPOTENT STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 42     EMBRYONIC STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 43     BACTERIAL CELLS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 44     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 45     CELL EXPANSION GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 46     REGENRATIVE MEDICINE AND STEM CELL RESEARCH APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 47     CANCER STUDIES APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 48     OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 49     CELL EXPANSION GLOBAL MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
      • TABLE 50     ACADEMIC AND RESEARCH INSTITUTE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 51     BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 52     HOSPITALS AND BIO BANKS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 53     OTHER END USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 54     NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 55     NORTH AMERICA CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 56     NORTH AMERICA CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 57     NORTH AMERICA CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 58     NORTH AMERICA CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 59     NORTH AMERICA CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 60     NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
      • TABLE 61     NORTH AMERICA HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 62     NORTH AMERICA ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 63     NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 64     NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
      • TABLE 65     EUROPEAN CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 66     EUROPEAN CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 67     EUROPEAN CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 68     EUROPEAN CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 69     EUROPEAN CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 70     EUROPEAN CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 71     EUROPEAN CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
      • TABLE 72     EUROPEAN HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 73     EUROPEAN ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 74     EUROPEAN CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 75     EUROPEAN CELL EXPANSION MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
      • TABLE 76     ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 77     ASIA PACIFIC CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 78     ASIA PACIFIC CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 79     ASIA PACIFIC CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 80     ASIA PACIFIC CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 81     ASIA PACIFIC CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 82     ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
      • TABLE 83     ASIA PACIFIC HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 84     ASIA PACIFIC ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 85     ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 86     ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
      • TABLE 87     ROW CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 88     ROW CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 89     ROW CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 90     ROW CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 91     ROW CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 92     ROW CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 93     ROW CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
      • TABLE 94     ROW HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 95     ROW ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 96     ROW CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 97     ROW CELL EXPANSION MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
      • TABLE 98     NEW PRODUCT LAUNCH (2014-2016)
      • TABLE 99     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016)
      • TABLE 100     OTHERS (2014-2016)
      • TABLE 101     MERGER AND ACQUISITION (2014-2016)
      • TABLE 102     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 103     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 104     BECTON DIKINSON AND COMPANY: LIFE SCIENCE REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 105     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 106     CORNING, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 107     CORNING, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 108     CORNING, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 109     DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 110     DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 111     DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 112     EPPENDORF AG: TOTAL REVENUE AND R&D EXPENSES (2013-2015) ($MN)
      • TABLE 113     EPPENDORF AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 114     GE: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 115     GE: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 116     GE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 117     LONZA GROUP LTD.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 118     LONZA GROUP LTD.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 119     LONZA GROUP LTD.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 120     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 121     MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 122     MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 123     TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 124     TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 125     TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
      • TABLE 126     THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 127     THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 128     THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)

      LIST OF FIGURES

      • FIGURE 1     CELL EXPANSION GLOBAL MARKET, BY REGION (2014-2022) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: CELL EXPANSION GLOBAL MARKET
      • FIGURE 3     CELL EXPANSION GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     CELL EXPANSION GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     CELL EXPANSION GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
      • FIGURE 6     CELL EXPANSION GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     CELL EXPANSION GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     CELL EXPANSION GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     CELL EXPANSION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015, (%)
      • FIGURE 11     SINGLE-USE BIOREACTOR MARKET REVENUE, BY MAJOR PLAYERS, 2015, (%)
      • FIGURE 12     CELL EXPANSION GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
      • FIGURE 13     CELL EXPANSION GLOBAL MARKET, BY PRODUCTS, (2014-2022) ($MN)
      • FIGURE 14     CELL EXPANSION INSTRUMENTS GLOBAL MARKET, BY TYPE, (2014-2022) ($MN)
      • FIGURE 15     CELL EXPANSION SUPPORTING EQUIPMENTSS GLOBAL MARKET, BY TYPE (2014-2022) ($MN)
      • FIGURE 16     CELL EXPANSION BIOREACTORS GLOBAL MARKET, BY TYPE, (2015 V’S 2022), ($MN)
      • FIGURE 17     CELL EXPANSION CONSUMABLES GLOBAL MARKET, BY TYPE, (2014-2022), ($MN)
      • FIGURE 18     CELL EXPANSION DISPOSABLES GLOBAL MARKET, BY TYPE, (2014-2022) ($MN)
      • FIGURE 19     CELL EXPANSION GLOBAL MARKET, BY CELL TYPES, (2015 V’S 2022) ($MN)
      • FIGURE 20     HUMAN CELL GLOBAL MARKET, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 21     ADULT CELL GLOBAL MARKET, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 22     CELL EXPANSION GLOBAL MARKET, BY APPLICATION, (2014-2022) ($MN)
      • FIGURE 23     CELL EXPANSION GLOBAL MARKET, BY END USERS, (2014-2022) ($MN)
      • FIGURE 24     CELL EXPANSION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • FIGURE 25     NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & END USERS, (2015 V’S 2022) ($MN)
      • FIGURE 26     EUROPE CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & END USERS, (2015 V’S 2022) ($MN)
      • FIGURE 27     ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & BY END USERS, (2015 V’S 2022) ($MN)
      • FIGURE 28     ROW CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS, END USERS (2015 V’S 2022) ($MN)
      • FIGURE 29     KEY GROWTH STRATEGIES (2014-2016)
      • FIGURE 30     NEW PRODUCT LAUNCH (2014-2016)
      • FIGURE 31     AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016)
      • FIGURE 32     SWOT: BECTON, DICKINSON AND COMPANY
      • FIGURE 33     SWOT: CORNING, INC.
      • FIGURE 34     SWOT: DANAHER CORPORATION
      • FIGURE 35     SWOT: EPPENDORF AG
      • FIGURE 36     SWOT: GE HEALTHCARE
      • FIGURE 37     SWOT: LONZA GROUP LTD.
      • FIGURE 38     SWOT: MERCK KGAA
      • FIGURE 39     SWOT: MILTENYI BIOTEC
      • FIGURE 40     SWOT: STEMCELL TECHNOLOGIES
      • FIGURE 41     SWOT: TERUMO CORPORATION
      • FIGURE 42     SWOT: THERMO FISHER SCIENTIFIC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     300MICRONS GMBH
      • 2     ABEC INC
      • 3     ACEA BIOSCIENCE, INC
      • 4     ALERE INC
      • 5     ANTIGEN AMERICA INC.
      • 6     APPLIKON BIOTECHNOLOGIES
      • 7     AUXILAB S.L
      • 8     AXOL BIOSCIENCE
      • 9     BBI BIOTEC
      • 10     BECTON, DICKINSON AND COMPANY
      • 11     BIOLOGICAL INDUSTRY
      • 12     BIOMERIEUX
      • 13     BIOREACTOR SCIENCES
      • 14     CELL APPLICATIONS, INC.
      • 15     CELLGENIX
      • 16     CELLTREAT SCIENTIFIC PRODUCTS
      • 17     CELPROGEN INC
      • 18     CHEMOMETEC USA INC
      • 19     COLE PARMER
      • 20     CORNING, INC.
      • 21     DANAHER CORPORATION
      • 22     DIAGENODE S.A
      • 23     EPPENDORF AG
      • 24     FINEESSE
      • 25     FLOWNAMICS
      • 26     GE HEALTHCARE
      • 27     GENLANTIS
      • 28     HAIER
      • 29     HANDYEM
      • 30     HETTICH LAB TECHNOLOGY
      • 31     HI-MEDIA
      • 32     HITACHI
      • 33     HUREL CORPORATION
      • 34     IBA
      • 35     INFORS HT
      • 36     INOXCVA
      • 37     LEICA BIOSYSTEMS
      • 38     LOGOS BIOSYSTEMS
      • 39     LONZA GROUP LTD.
      • 40     MEMMERT GMBH
      • 41     MERCK KGAA
      • 42     MILTENYI BIOTEC
      • 43     MOLECULAR DEVICES
      • 44     OLYMPUS CORPORATION
      • 45     PALL CORPORATION
      • 46     PBS BIOTECH
      • 47     PERCELL BIOLYTICA AB
      • 48     PRODIZEN, INC.
      • 49     R&D SYSTEMS
      • 50     REACHBIO LLC
      • 51     REINNERVATE
      • 52     ROOSTERBIO
      • 53     RR MECHETRONICS
      • 54     SARTORIOUS AG
      • 55     STEMBIOSYS
      • 56     STEMCELL TECHNOLOGIES
      • 57     SUNRISE SCIENCE PRODUCTS, INC.
      • 58     SYNTHECON
      • 59     SYSMEX
      • 60     TAKARA BIO
      • 61     TERUMO CORPORATION
      • 62     THERMO FISHER SCIENTIFIC
      • 63     TOYO GOSEI CO., LTD
      • 64     VISION SCIENTIFIC CO LTD
      • 65     VIVO BIOSCIENCES INC.
      • 66     ZEN-BIO INC